Exact Mass: 388.1643

Exact Mass Matches: 388.1643

Found 245 metabolites which its exact mass value is equals to given mass value 388.1643, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cetirizine

2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid

C21H25ClN2O3 (388.1554)


Cetirizine is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth. A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects. Cetirizine hydrochloride is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].

   

12-Hydroxyjasmonic acid glucoside

2-[(1R,2R)-3-oxo-2-[(2Z)-5-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


12-hydroxyjasmonic acid glucoside, also known as tuberonic acid beta-D-glucoside, is a member of the class of compounds known as fatty acyl glycosides of mono- and disaccharides. Fatty acyl glycosides of mono- and disaccharides are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol. 12-hydroxyjasmonic acid glucoside is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 12-hydroxyjasmonic acid glucoside can be found in potato, which makes 12-hydroxyjasmonic acid glucoside a potential biomarker for the consumption of this food product.

   

Nisoldipine

3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C20H24N2O6 (388.1634)


Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

7-Epi-12-hydroxyjasmonic acid glucoside

2-{3-oxo-2-[(2E)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl}acetic acid

C18H28O9 (388.1733)


7-Epi-12-hydroxyjasmonic acid glucoside is found in alcoholic beverages. 7-Epi-12-hydroxyjasmonic acid glucoside is isolated from potato leaves (Solanum tuberosum). Isolated from potato leaves (Solanum tuberosum). 7-Epi-12-hydroxyjasmonic acid glucoside is found in alcoholic beverages and potato.

   

beta-D-Glucopyranosyl-11-hydroxyjasmonic acid

2-{3-oxo-2-[(2E)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl}acetic acid

C18H28O9 (388.1733)


beta-D-Glucopyranosyl-11-hydroxyjasmonic acid is found in potato. beta-D-Glucopyranosyl-11-hydroxyjasmonic acid is a constituent of Solanum tuberosum (potato). Constituent of Solanum tuberosum (potato). 11-Hydroxyjasmonic acid glucoside is found in potato.

   

2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-xyloside

2-{3-hydroxy-2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]propoxy}oxane-3,4,5-triol

C18H28O9 (388.1733)


2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-xyloside is a constituent of Scotch pine (Pinus sylvestris) bark. 2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-xyloside can be used as famine food. Constituent of Scotch pine (Pinus sylvestris) bark. Famine food

   

Bepotastine

4-{4-[(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid

C21H25ClN2O3 (388.1554)


Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion®. It is currently undergoing trials in the U.S.

   

Levocetirizine

Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride

C21H25ClN2O3 (388.1554)


Levocetirizine is a second-generation piperazine H1-antihistamine. It has also been labeled as a third-generation antihistamine because it is developed from a second-generation antihistamine (cetirizine). R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine ((R)-Cetirizine) is a third-generation peripheral H1-receptor antagonist. Levocetirizine is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].

   

N,N'-Bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid

2-({2-[(carboxymethyl)[(2-hydroxyphenyl)methyl]amino]ethyl}[(2-hydroxyphenyl)methyl]amino)acetic acid

C20H24N2O6 (388.1634)


D064449 - Sequestering Agents > D002614 - Chelating Agents

   

m-Nisoldipine

3-Methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid

C20H24N2O6 (388.1634)


   

1,3,7-Trimethyl-8-(1,3,7-trimethyl-2,6-dioxo-8H-purin-9-yl)purine-2,6-dione

1,1,3,3,7,7-hexamethyl-7,8-dihydro-1H,1H,2H,2H,3H,3H,6H,6H,7H-[8,9-bipurine]-2,2,6,6-tetrone

C16H20N8O4 (388.1607)


   

trifluoroacetyl-l-lysyl-l-alaninanilide

6-Amino-N-[1-(phenyl-C-hydroxycarbonimidoyl)ethyl]-2-[(2,2,2-trifluoro-1-hydroxyethylidene)amino]hexanimidate

C17H23F3N4O3 (388.1722)


   

3-O-Methyl 5-O-(2-methylpropyl) (4S)-2,6-dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate

2,6-dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-(2-methylpropyl) ester

C20H24N2O6 (388.1634)


   
   

Lespecyrtin E1

Lespecyrtin E1

C25H24O4 (388.1675)


   

3-Deoxy-MS-II

3-Deoxy-MS-II

C25H24O4 (388.1675)


   

Isoerythrin-A 4-(3-methylbut-2-enyl)ether

Isoerythrin-A 4-(3-methylbut-2-enyl)ether

C25H24O4 (388.1675)


   
   

Kanzonol E

2- (2,2-Dimethyl-2H-1-benzopyran-6-yl) -7-hydroxy-6- (3-methyl-2-butenyl) -4H-1-benzopyran-4-one

C25H24O4 (388.1675)


   

Spinoflavanone A

5-Hydroxy-6- (3-methyl-1,3-butadienyl) -6",6"-dimethylpyrano [ 2",3":7,8 ] flavanone

C25H24O4 (388.1675)


   

Paratocarpin A

Bis (6",6"-dimethylpyrano) [ 2",3":4,3 ] [ 2",3":4,3 ] -2-hydroxychalcone

C25H24O4 (388.1675)


   

Flemiculosin

(E) -1- (5-Hydroxy-2,2,8,8-tetramethyl-2H,8H-benzo [ 1,2-b:3,4-b ] dipyran-6-yl) -3-phenyl-2-propen-1-one

C25H24O4 (388.1675)


   

MCULE-6601387315

MCULE-6601387315

C21H20N6O2 (388.1648)


   

7-Formyl-3-methylene-6E-octen-1,5-diol-1-O-beta-D-(2-O-acetylglucopyranoside)|7-Formyl-3-methylene-6E-octen-1,5-diol-1-O-beta-D-<2-O-acetylglucopyranoside>

7-Formyl-3-methylene-6E-octen-1,5-diol-1-O-beta-D-(2-O-acetylglucopyranoside)|7-Formyl-3-methylene-6E-octen-1,5-diol-1-O-beta-D-<2-O-acetylglucopyranoside>

C18H28O9 (388.1733)


   

artochamin K

artochamin K

C25H24O4 (388.1675)


   

Nuezhengalaside

Nuezhengalaside

C18H28O9 (388.1733)


   

Qingjueine I

Qingjueine I

C18H28O9 (388.1733)


   

2-hydroxy-6-methoxy-6,6-dimethyl-chromeno-[4,3:2,3]-chalcone

2-hydroxy-6-methoxy-6,6-dimethyl-chromeno-[4,3:2,3]-chalcone

C25H24O4 (388.1675)


   

3-(3,4,5-trimethoxyphenyl)propyl beta-D-glucopyranoside|dihydrosyringenin 9-O-beta-D-glucopyranoside

3-(3,4,5-trimethoxyphenyl)propyl beta-D-glucopyranoside|dihydrosyringenin 9-O-beta-D-glucopyranoside

C18H28O9 (388.1733)


   

8,8-Dimethyl-3-[4-(3-methylbut-2-enyloxy)phenyl]-8H-pyrano[2,3-f]chromen-4-one

8,8-Dimethyl-3-[4-(3-methylbut-2-enyloxy)phenyl]-8H-pyrano[2,3-f]chromen-4-one

C25H24O4 (388.1675)


   
   

8-epi-loganin

8-epi-loganin

C18H28O9 (388.1733)


   

14-chloro-15-hydroxy-vincadifformine

14-chloro-15-hydroxy-vincadifformine

C21H25ClN2O3 (388.1554)


   
   

(+)-Ajamxanthone

(+)-Ajamxanthone

C25H24O4 (388.1675)


   

(Z)-5xi-hydroxy-6xi,7xi,8xi-triacetoxydodeca-2-enoic acid

(Z)-5xi-hydroxy-6xi,7xi,8xi-triacetoxydodeca-2-enoic acid

C18H28O9 (388.1733)


   

2-O-Acetyl-1-O-(3-methylbutanoyl)-6-O-tigloyl-beta-D-glucopyranose

2-O-Acetyl-1-O-(3-methylbutanoyl)-6-O-tigloyl-beta-D-glucopyranose

C18H28O9 (388.1733)


   

O-beta-D-Glucopyranoside---Tuberonic acid

O-beta-D-Glucopyranoside---Tuberonic acid

C18H28O9 (388.1733)


   
   
   

Lamuran

methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7,18-pentaene-19-carboxylate hydrochloride

C21H25ClN2O3 (388.1554)


   

cetirizine

Levocetirizine

C21H25ClN2O3 (388.1554)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth.; A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.; Cetirizine hydrochloride is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth. [HMDB] CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4258; ORIGINAL_PRECURSOR_SCAN_NO 4255 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4282; ORIGINAL_PRECURSOR_SCAN_NO 4280 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4227; ORIGINAL_PRECURSOR_SCAN_NO 4225 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4253; ORIGINAL_PRECURSOR_SCAN_NO 4251 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4259; ORIGINAL_PRECURSOR_SCAN_NO 4258 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4253; ORIGINAL_PRECURSOR_SCAN_NO 4250 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8478; ORIGINAL_PRECURSOR_SCAN_NO 8477 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8516; ORIGINAL_PRECURSOR_SCAN_NO 8514 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8525; ORIGINAL_PRECURSOR_SCAN_NO 8524 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8560; ORIGINAL_PRECURSOR_SCAN_NO 8559 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8566; ORIGINAL_PRECURSOR_SCAN_NO 8564 CONFIDENCE standard compound; INTERNAL_ID 535; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8574; ORIGINAL_PRECURSOR_SCAN_NO 8573 CONFIDENCE standard compound; INTERNAL_ID 2124 CONFIDENCE standard compound; INTERNAL_ID 8582 CONFIDENCE standard compound; INTERNAL_ID 4110 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2772 Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3]. Levocetirizine ((R)-Cetirizine) is a third-generation peripheral H1-receptor antagonist. Levocetirizine is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].

   

nisoldipine

Nisoldipine (Sular)

C20H24N2O6 (388.1634)


C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

C18H28O9_Cyclopentaneacetic acid, 2-[(2Z)-5-(hexopyranosyloxy)-2-penten-1-yl]-3-oxo-, (1R,2R)

NCGC00380878-01_C18H28O9_Cyclopentaneacetic acid, 2-[(2Z)-5-(hexopyranosyloxy)-2-penten-1-yl]-3-oxo-, (1R,2R)-

C18H28O9 (388.1733)


   

Levocetirizine

Levocetirizine

C21H25ClN2O3 (388.1554)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine ((R)-Cetirizine) is a third-generation peripheral H1-receptor antagonist. Levocetirizine is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].

   

12:4+3O fatty acyl hexoside

12:4+3O fatty acyl hexoside

C18H28O9 (388.1733)


Annotation level-3

   

Ala Ala Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Ala Asp Pro Ser

(3S)-3-[(2S)-2-aminopropanamido]-4-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Ala Asp Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ala Gly Asn Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Ala Gly Gln Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Ala Asn Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Ala Asn Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Ala Asn Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Ala Asn Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetic acid

C14H24N6O7 (388.1706)


   

Ala Pro Asp Ser

(3S)-3-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C15H24N4O8 (388.1594)


   

Ala Pro Ser Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]butanedioic acid

C15H24N4O8 (388.1594)


   

Ala Gln Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Ala Gln Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetic acid

C14H24N6O7 (388.1706)


   

Ala Ser Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ala Ser Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O8 (388.1594)


   

Asp Ala Pro Ser

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C15H24N4O8 (388.1594)


   

Asp Ala Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Asp Gly Pro Thr

(3S)-3-amino-3-({2-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)propanoic acid

C15H24N4O8 (388.1594)


   

Asp Gly Thr Pro

(2S)-1-[(2S,3R)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Asp Pro Ala Ser

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Asp Pro Gly Thr

(3S)-3-amino-4-[(2S)-2-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Asp Pro Ser Ala

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Asp Pro Thr Gly

(3S)-3-amino-4-[(2S)-2-{[(1S,2R)-1-[(carboxymethyl)carbamoyl]-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Asp Ser Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Asp Ser Pro Ala

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]carbamoyl}propanoic acid

C15H24N4O8 (388.1594)


   

Asp Thr Gly Pro

(2S)-1-{2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Asp Thr Pro Gly

(3S)-3-amino-3-{[(2S,3R)-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]carbamoyl}propanoic acid

C15H24N4O8 (388.1594)


   

Glu Gly Pro Ser

(4S)-4-amino-4-({2-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)butanoic acid

C15H24N4O8 (388.1594)


   

Glu Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Glu Pro Gly Ser

(4S)-4-amino-5-[(2S)-2-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O8 (388.1594)


   

Glu Pro Ser Gly

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O8 (388.1594)


   

Glu Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Glu Ser Pro Gly

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]carbamoyl}butanoic acid

C15H24N4O8 (388.1594)


   

Gly Ala Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Gly Ala Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Gly Asp Pro Thr

(3S)-3-(2-aminoacetamido)-4-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Gly Asp Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Gly Glu Pro Ser

(4S)-4-(2-aminoacetamido)-5-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O8 (388.1594)


   

Gly Glu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Gly Gly Gln Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Gly Asn Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Gly Asn Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Gly Pro Asp Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-3-hydroxybutanoic acid

C15H24N4O8 (388.1594)


   

Gly Pro Glu Ser

(4S)-4-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C15H24N4O8 (388.1594)


   

Gly Pro Ser Glu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]pentanedioic acid

C15H24N4O8 (388.1594)


   

Gly Pro Thr Asp

(2S)-2-[(2S,3R)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]butanedioic acid

C15H24N4O8 (388.1594)


   

Gly Gln Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Gly Gln Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Gly Gln Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Gly Gln Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetic acid

C14H24N6O7 (388.1706)


   

Gly Ser Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Gly Ser Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C15H24N4O8 (388.1594)


   

Gly Thr Asp Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Gly Thr Pro Asp

(2S)-2-{[(2S)-1-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O8 (388.1594)


   

Asn Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Asn Ala Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Asn Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Asn Ala Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-carbamoylbutanamido]acetic acid

C14H24N6O7 (388.1706)


   

Asn Gly Ala Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Asn Gly Gln Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Asn Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Asn Gln Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]propanamido]acetic acid

C14H24N6O7 (388.1706)


   

Asn Gln Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetamido}propanoic acid

C14H24N6O7 (388.1706)


   

Pro Ala Asp Ser

(3S)-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Ala Ser Asp

(2S)-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C15H24N4O8 (388.1594)


   

Pro Asp Ala Ser

(3S)-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Asp Gly Thr

(2S,3R)-2-{2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-hydroxybutanoic acid

C15H24N4O8 (388.1594)


   

Pro Asp Ser Ala

(3S)-3-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Asp Thr Gly

(3S)-3-{[(1S,2R)-1-[(carboxymethyl)carbamoyl]-2-hydroxypropyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Glu Gly Ser

(4S)-4-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C15H24N4O8 (388.1594)


   

Pro Glu Ser Gly

(4S)-4-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C15H24N4O8 (388.1594)


   

Pro Gly Asp Thr

(2S,3R)-2-[(2S)-3-carboxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-hydroxybutanoic acid

C15H24N4O8 (388.1594)


   

Pro Gly Glu Ser

(4S)-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-4-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoic acid

C15H24N4O8 (388.1594)


   

Pro Gly Ser Glu

(2S)-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanedioic acid

C15H24N4O8 (388.1594)


   

Pro Gly Thr Asp

(2S)-2-[(2S,3R)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]butanedioic acid

C15H24N4O8 (388.1594)


   
   

Pro Ser Ala Asp

(2S)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C15H24N4O8 (388.1594)


   

Pro Ser Asp Ala

(3S)-3-{[(1S)-1-carboxyethyl]carbamoyl}-3-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Ser Glu Gly

(4S)-4-[(carboxymethyl)carbamoyl]-4-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C15H24N4O8 (388.1594)


   

Pro Ser Gly Glu

(2S)-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanedioic acid

C15H24N4O8 (388.1594)


   

Pro Thr Asp Gly

(3S)-3-[(carboxymethyl)carbamoyl]-3-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanoic acid

C15H24N4O8 (388.1594)


   

Pro Thr Gly Asp

(2S)-2-{2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}butanedioic acid

C15H24N4O8 (388.1594)


   

Gln Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Gln Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C14H24N6O7 (388.1706)


   

Gln Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C14H24N6O7 (388.1706)


   

Gln Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C14H24N6O7 (388.1706)


   

Gln Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C14H24N6O7 (388.1706)


   

Gln Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C14H24N6O7 (388.1706)


   

Gln Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C14H24N6O7 (388.1706)


   

Gln Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C14H24N6O7 (388.1706)


   

Gln Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C14H24N6O7 (388.1706)


   

Ser Ala Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ser Ala Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O8 (388.1594)


   

Ser Asp Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ser Asp Pro Ala

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-4-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Ser Glu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ser Glu Pro Gly

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-5-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O8 (388.1594)


   

Ser Gly Glu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Ser Gly Pro Glu

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}pentanedioic acid

C15H24N4O8 (388.1594)


   

Ser Pro Ala Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}propanamido]butanedioic acid

C15H24N4O8 (388.1594)


   

Ser Pro Asp Ala

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H24N4O8 (388.1594)


   

Ser Pro Glu Gly

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H24N4O8 (388.1594)


   

Ser Pro Gly Glu

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)pentanedioic acid

C15H24N4O8 (388.1594)


   

Thr Asp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Thr Asp Pro Gly

(3S)-3-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O8 (388.1594)


   

Thr Gly Asp Pro

(2S)-1-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O8 (388.1594)


   

Thr Gly Pro Asp

(2S)-2-{[(2S)-1-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetyl}pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O8 (388.1594)


   

Thr Pro Asp Gly

(3S)-3-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H24N4O8 (388.1594)


   

Thr Pro Gly Asp

(2S)-2-(2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}acetamido)butanedioic acid

C15H24N4O8 (388.1594)


   

Bepotastine

4-{4-[(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid

C21H25ClN2O3 (388.1554)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bepotastine is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].

   

b-D-Glucopyranosyl-11-hydroxyjasmonic acid

2-{3-oxo-2-[(2E)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl}acetic acid

C18H28O9 (388.1733)


   

7-Epi-12-hydroxyjasmonic acid glucoside

2-{3-oxo-2-[(2E)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl}acetic acid

C18H28O9 (388.1733)


   

2-[4-(3-Hydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol 1-xyloside

2-{3-hydroxy-2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]propoxy}oxane-3,4,5-triol

C18H28O9 (388.1733)


   

Tuberonic acid glucoside

(1R,2S)-3-oxo-2-(5-O-beta-D-glucopyranosyloxy-2Z-pentenyl)-cyclopentaneacetic acid

C18H28O9 (388.1733)


   

niobium n-propoxide

niobium n-propoxide

C15H35NbO5 (388.1548)


   

NIOBIUM ISOPROPOXIDE

NIOBIUM ISOPROPOXIDE

C15H35NbO5 (388.1548)


   

Tributyl(trimethylsilylethynyl)tin

Tributyl(trimethylsilylethynyl)tin

C17H36SiSn (388.1608)


   

2-(4-Boc-piperazino)-2-[2-(trifluoromethyl)phenyl]acetic acid

2-(4-Boc-piperazino)-2-[2-(trifluoromethyl)phenyl]acetic acid

C18H23F3N2O4 (388.161)


   

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(3-fluorophenyl)-N-(phenylmethyl)- (9CI)

Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(3-fluorophenyl)-N-(phenylmethyl)- (9CI)

C23H21FN4O (388.1699)


   
   

ALPHA BETA-BIS(PHENYLAZO)STILBENE

ALPHA BETA-BIS(PHENYLAZO)STILBENE

C26H20N4 (388.1688)


   

RS 67333 hydrochloride

RS 67333 hydrochloride

C19H30Cl2N2O2 (388.1684)


RS 67333 hydrochloride is a potent and selective 5-HT4 receptor (5-HT4R) partial agonist with a pKi of 8.7 in guinea-pig striatum. RS 67333 hydrochloride exhibits lower affinities at several other receptors including 5-HT1A, 5-HT1D, 5-HT2A, 5-HT2C, dopamine D1, D2 and muscarinic M1-M3 receptors. RS 67333 hydrochloride has neuroprotective effects, and can be used for Alzheimer's disease research[1].

   

SB269970 HCl

SB269970 HCl

C18H29ClN2O3S (388.1587)


SB-269970 hydrochloride is a potent, selective and brain-penetrant 5-HT7 receptor antagonist with a pKi of 8.3. SB-269970 hydrochloride exhibits >50-fold selectivity against other 5-HT receptors[1][2].

   

2-(4-BOC-PIPERAZINYL)-2-(3-TRIFLUOROMETHYL-PHENYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(3-TRIFLUOROMETHYL-PHENYL)ACETIC ACID

C18H23F3N2O4 (388.161)


   

Terabutyl titanate

Terabutyl titanate

C16H36O4Ti2 (388.1572)


   

METHANESULFONAMIDE,N-(1,4-DIHYDRO-2,4-DIOXO-2H-3,1-BENZOXAZIN-7-YL)-

METHANESULFONAMIDE,N-(1,4-DIHYDRO-2,4-DIOXO-2H-3,1-BENZOXAZIN-7-YL)-

C18H23F3N2O4 (388.161)


   

Pinacyanol Chloride

Pinacyanol Chloride

C25H25ClN2 (388.1706)


   

DI-9H-FLUOREN-9-YLDIMETHYLSILANE

DI-9H-FLUOREN-9-YLDIMETHYLSILANE

C28H24Si (388.1647)


   

5-Phenyl-2-trityltetrazole

5-Phenyl-2-trityltetrazole

C26H20N4 (388.1688)


   

4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid

4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid

C21H25ClN2O3 (388.1554)


   

(R)-Nisoldipine

(R)-Nisoldipine

C20H24N2O6 (388.1634)


   

6-[4-(3-chlorophenyl)-1-piperazinyl]-3-cyclohexyl-1H-pyrimidine-2,4-dione

6-[4-(3-chlorophenyl)-1-piperazinyl]-3-cyclohexyl-1H-pyrimidine-2,4-dione

C20H25ClN4O2 (388.1666)


   

(S)-Nisoldipine

(S)-Nisoldipine

C20H24N2O6 (388.1634)


   

Cyclopentaneacetic acid, 2-[(2Z)-5-(beta-D-glucopyranosyloxy)-2-penten-1-yl]-3-oxo-, (1R,2S)-

Cyclopentaneacetic acid, 2-[(2Z)-5-(beta-D-glucopyranosyloxy)-2-penten-1-yl]-3-oxo-, (1R,2S)-

C18H28O9 (388.1733)


   

2-[3-oxo-2-[(Z)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

2-[3-oxo-2-[(Z)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

6-amino-N-(1-anilino-1-oxopropan-2-yl)-2-[(2,2,2-trifluoroacetyl)amino]hexanamide

6-amino-N-(1-anilino-1-oxopropan-2-yl)-2-[(2,2,2-trifluoroacetyl)amino]hexanamide

C17H23F3N4O3 (388.1722)


   

N,4-Dimethyl-N-{2-Oxo-2-[4-(Pyridin-2-Yl)piperazin-1-Yl]ethyl}benzene-1-Sulfonamide

N,4-Dimethyl-N-{2-Oxo-2-[4-(Pyridin-2-Yl)piperazin-1-Yl]ethyl}benzene-1-Sulfonamide

C19H24N4O3S (388.1569)


   

2-[(1R,2R)-3-oxo-2-[(Z)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

2-[(1R,2R)-3-oxo-2-[(Z)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

1,3-Diethyl-5-[[4-(4-morpholinyl)anilino]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

1,3-Diethyl-5-[[4-(4-morpholinyl)anilino]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

C19H24N4O3S (388.1569)


   

N-[3-(diethylamino)propyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide

N-[3-(diethylamino)propyl]-6-(4-fluorophenyl)-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide

C20H25FN4OS (388.1733)


   

1-[2-[(4-Pentoxyphenyl)methylthio]ethyl]-3-phenylthiourea

1-[2-[(4-Pentoxyphenyl)methylthio]ethyl]-3-phenylthiourea

C21H28N2OS2 (388.1643)


   

3-(4-Chlorophenoxy)-4-[(3-methoxypropylamino)methyl]-1-(2-methylphenyl)-2-azetidinone

3-(4-Chlorophenoxy)-4-[(3-methoxypropylamino)methyl]-1-(2-methylphenyl)-2-azetidinone

C21H25ClN2O3 (388.1554)


   

1-(1H-imidazol-5-ylsulfonyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-piperidinecarboxamide

1-(1H-imidazol-5-ylsulfonyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-piperidinecarboxamide

C19H24N4O3S (388.1569)


   

1,4:3,6-Dianhydro-2,5-dideoxy-2-{[4-(3-fluorophenyl)-2-pyrimidinyl]amino}-5-[(methoxyacetyl)amino]-l-iditol

1,4:3,6-Dianhydro-2,5-dideoxy-2-{[4-(3-fluorophenyl)-2-pyrimidinyl]amino}-5-[(methoxyacetyl)amino]-l-iditol

C19H21FN4O4 (388.1547)


   

(2S,5R,6R)-6-({5-[(4-aminophenyl)imino]pentylidene}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2S,5R,6R)-6-({5-[(4-aminophenyl)imino]pentylidene}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C19H24N4O3S (388.1569)


   

8-Benzyloxy-5,7-diphenylquinoline(1+)

8-Benzyloxy-5,7-diphenylquinoline(1+)

C28H22NO+ (388.1701)


   

(1R,5S)-N-(4-fluorophenyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-N-(4-fluorophenyl)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C23H21FN4O (388.1699)


   

(1R,5S)-N-(2-fluorophenyl)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-N-(2-fluorophenyl)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C23H21FN4O (388.1699)


   
   
   
   

3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

C20H24N2O6 (388.1634)


   

beta-D-Glucopyranosyl-11-hydroxyjasmonic acid

beta-D-Glucopyranosyl-11-hydroxyjasmonic acid

C18H28O9 (388.1733)


   

2,6-dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-(2-methylpropyl) ester

2,6-dimethyl-4-(2-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-(2-methylpropyl) ester

C20H24N2O6 (388.1634)


   

2-[3-Oxo-2-[5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

2-[3-Oxo-2-[5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypent-2-enyl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

6beta-({5-[(p-aminophenyl)imino]pentylidene}amino)penicillanic acid

6beta-({5-[(p-aminophenyl)imino]pentylidene}amino)penicillanic acid

C19H24N4O3S (388.1569)


Penicillanic acid carrying a (p-aminophenyl)imino]pentylidene}amino substituent at the 6beta position. It has been used as a hapten in the production of a generic monoclonal antibody for determining penicillin residues in milk.

   
   
   
   

EST73502 (monohydrochloride)

EST73502 (monohydrochloride)

C19H27ClF2N2O2 (388.1729)


EST73502 monohydrochloride is a selective, orally active and blood-brain barrier (BBB) penetrant dual μ-opioid receptor (MOR) agonist and σ1 receptor (σ1R) antagonist, with Kis of 64 nM and 118 nM for MOR and σ1R, respectively. EST73502 monohydrochloride has antinociceptive activity[1].

   

6,6,10,10-tetramethyl-2-phenyl-2,3-dihydro-1,5,9-trioxatriphenylen-4-one

6,6,10,10-tetramethyl-2-phenyl-2,3-dihydro-1,5,9-trioxatriphenylen-4-one

C25H24O4 (388.1675)


   

2-(1-hydroxycyclopropyl)-4-[(2e)-2-methyldec-2-enoyl]-5-oxooxolane-3-sulfonic acid

2-(1-hydroxycyclopropyl)-4-[(2e)-2-methyldec-2-enoyl]-5-oxooxolane-3-sulfonic acid

C18H28O7S (388.1556)


   

8,8-dimethyl-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrano[2,3-h]chromen-4-one

8,8-dimethyl-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrano[2,3-h]chromen-4-one

C25H24O4 (388.1675)


   

(1r,2r)-5'-hydroxyjasmonicacid 5'-o-β-d-glu-copyranoside

NA

C18H28O9 (388.1733)


{"Ingredient_id": "HBIN003056","Ingredient_name": "(1r,2r)-5'-hydroxyjasmonicacid 5'-o-\u03b2-d-glu-copyranoside","Alias": "NA","Ingredient_formula": "C18H28O9","Ingredient_Smile": "C1CC(=O)C(C1CC(=O)O)CC=CCCOC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10269","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[3-(3,4,5-trimethoxyphenyl)propoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[3-(3,4,5-trimethoxyphenyl)propoxy]oxane-3,4,5-triol

C18H28O9 (388.1733)


   

4,5-dihydroxy-2-[(5-hydroxy-7-methyl-3-methylidene-8-oxooct-6-en-1-yl)oxy]-6-(hydroxymethyl)oxan-3-yl acetate

4,5-dihydroxy-2-[(5-hydroxy-7-methyl-3-methylidene-8-oxooct-6-en-1-yl)oxy]-6-(hydroxymethyl)oxan-3-yl acetate

C18H28O9 (388.1733)


   

10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

C20H24N2O6 (388.1634)


   

10-methoxy-6,6,14,14-tetramethyl-7-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-1(21),2(11),3(8),4,9,12,15,17,19-nonaene-16,17-diol

10-methoxy-6,6,14,14-tetramethyl-7-oxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-1(21),2(11),3(8),4,9,12,15,17,19-nonaene-16,17-diol

C25H24O4 (388.1675)


   

(1r,14r)-7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

(1r,14r)-7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

C25H24O4 (388.1675)


   

n-[6-chloro-7-ethenyl-8a-hydroxy-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-5,6,8,10a-tetrahydroanthracen-1-yl]carboximidic acid

n-[6-chloro-7-ethenyl-8a-hydroxy-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-5,6,8,10a-tetrahydroanthracen-1-yl]carboximidic acid

C21H25ClN2O3 (388.1554)


   

(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(5r,6e)-5-hydroxy-7-methyl-3-methylidene-8-oxooct-6-en-1-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate

(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(5r,6e)-5-hydroxy-7-methyl-3-methylidene-8-oxooct-6-en-1-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate

C18H28O9 (388.1733)


   

(2e)-1-[(10ar)-4-hydroxy-2-methoxy-7,7-dimethyl-8,10a-dihydroxanthen-3-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(10ar)-4-hydroxy-2-methoxy-7,7-dimethyl-8,10a-dihydroxanthen-3-yl]-3-phenylprop-2-en-1-one

C25H24O4 (388.1675)


   

methyl (1r,4ar,7s,7as)-1-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1r,4ar,7s,7as)-1-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

[(1r,2s)-3-oxo-2-[(2z,4r)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetic acid

[(1r,2s)-3-oxo-2-[(2z,4r)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

methyl 1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl 1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

2-(1-{[(2e)-2-methyldec-2-enoyl]oxy}cyclopropyl)-5-oxooxolane-3-sulfonic acid

2-(1-{[(2e)-2-methyldec-2-enoyl]oxy}cyclopropyl)-5-oxooxolane-3-sulfonic acid

C18H28O7S (388.1556)


   

(2s)-6,6,10,10-tetramethyl-2-phenyl-2,3-dihydro-1,5,9-trioxatriphenylen-4-one

(2s)-6,6,10,10-tetramethyl-2-phenyl-2,3-dihydro-1,5,9-trioxatriphenylen-4-one

C25H24O4 (388.1675)


   

2-(hydroxymethyl)-6-[3-(3,4,5-trimethoxyphenyl)propoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[3-(3,4,5-trimethoxyphenyl)propoxy]oxane-3,4,5-triol

C18H28O9 (388.1733)


   

1-(4-hydroxy-2-methoxy-7,7-dimethyl-8,10a-dihydroxanthen-3-yl)-3-phenylprop-2-en-1-one

1-(4-hydroxy-2-methoxy-7,7-dimethyl-8,10a-dihydroxanthen-3-yl)-3-phenylprop-2-en-1-one

C25H24O4 (388.1675)


   

(1's,3s,3's,6's,9's,10'r)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

(1's,3s,3's,6's,9's,10'r)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

C20H24N2O6 (388.1634)


   

[3-oxo-2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl)cyclopentyl]acetic acid

[3-oxo-2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl)cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

methyl (1r,4ar,7s,7as)-1-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1r,4ar,7s,7as)-1-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

[(1s,2s)-3-oxo-2-[(2z)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetic acid

[(1s,2s)-3-oxo-2-[(2z)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

(1's,3s,3's,6's,9'r,10'r)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

(1's,3s,3's,6's,9'r,10'r)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

C20H24N2O6 (388.1634)


   

5-hydroxy-8,8-dimethyl-6-(3-methylbuta-1,3-dien-1-yl)-2-phenyl-2h,3h-pyrano[2,3-f]chromen-4-one

5-hydroxy-8,8-dimethyl-6-(3-methylbuta-1,3-dien-1-yl)-2-phenyl-2h,3h-pyrano[2,3-f]chromen-4-one

C25H24O4 (388.1675)


   

methyl 7-methyl-1-{[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl 7-methyl-1-{[3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

n-[(6r,7r,8s,8as,10ar)-6-chloro-7-ethenyl-8a-hydroxy-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-5,6,8,10a-tetrahydroanthracen-1-yl]carboximidic acid

n-[(6r,7r,8s,8as,10ar)-6-chloro-7-ethenyl-8a-hydroxy-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-5,6,8,10a-tetrahydroanthracen-1-yl]carboximidic acid

C21H25ClN2O3 (388.1554)


   

(1's,3s,3's,6's,9'r,10's)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

(1's,3s,3's,6's,9'r,10's)-10'-hydroxy-1,6-dimethoxy-1'-propanoyl-7'-oxa-2'-azaspiro[indole-3,5'-tricyclo[4.3.1.0³,⁹]decan]-2-one

C20H24N2O6 (388.1634)


   

(2r)-2-(2,2-dimethylchromen-6-yl)-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one

(2r)-2-(2,2-dimethylchromen-6-yl)-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one

C25H24O4 (388.1675)


   

6,7,8-tris(acetyloxy)-5-hydroxydodec-2-enoic acid

6,7,8-tris(acetyloxy)-5-hydroxydodec-2-enoic acid

C18H28O9 (388.1733)


   

(2z,5r,6r,7s,8s)-6,7,8-tris(acetyloxy)-5-hydroxydodec-2-enoic acid

(2z,5r,6r,7s,8s)-6,7,8-tris(acetyloxy)-5-hydroxydodec-2-enoic acid

C18H28O9 (388.1733)


   

methyl (1r,4ar,7s,7as)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1r,4ar,7s,7as)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

(2s,3r,4s,5r)-2-[(2r)-3-hydroxy-2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]propoxy]oxane-3,4,5-triol

(2s,3r,4s,5r)-2-[(2r)-3-hydroxy-2-[4-(3-hydroxypropyl)-2-methoxyphenoxy]propoxy]oxane-3,4,5-triol

C18H28O9 (388.1733)


   

(1s,14s)-7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

(1s,14s)-7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

C25H24O4 (388.1675)


   

methyl 1-{[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl 1-{[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C18H28O9 (388.1733)


   

(2s)-2-(2,2-dimethylchromen-6-yl)-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one

(2s)-2-(2,2-dimethylchromen-6-yl)-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one

C25H24O4 (388.1675)


   

[3-oxo-2-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl)cyclopentyl]acetic acid

[3-oxo-2-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl)cyclopentyl]acetic acid

C18H28O9 (388.1733)


   

7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

7,7,20,20-tetramethyl-8,12,19,25-tetraoxahexacyclo[12.11.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-2(11),3,5,9,15,17,21,23-octaene

C25H24O4 (388.1675)